MedPath

The effect of green coffee supplementation on patients with polycystic ovary syndrome

Phase 3
Conditions
Polycystic ovary syndrom.
Polycystic ovarian syndrome
Registration Number
IRCT20180711040428N1
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
40
Inclusion Criteria

Having polycystic ovarian syndrome
Age group between 20 and 40 years old
Use of pcos syndrome drugs
Body mass index from 18.5 to 39.9

Exclusion Criteria

The desire to get pregnant while studying
Being pregnant
Thyroid and renal failure
Consuming food supplements
Coffee susceptibility
Acute abnormalities in women with polycystic ovary syndrome during the research period

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Androgens. Timepoint: Before starting the study and 60 days after taking the green coffee pill. Method of measurement: Elisa device.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath